InvestorsHub Logo
Followers 25
Posts 1336
Boards Moderated 0
Alias Born 11/15/2016

Re: None

Thursday, 10/05/2017 1:54:38 PM

Thursday, October 05, 2017 1:54:38 PM

Post# of 203912
MM MYELOMA STUDY MOVING FORWARD: according to last 10q


? Expect to negotiate agreement and submit a clinical trial protocol to the Israeli Institutional Review Board and receive its approval to commence a clinical study

? Drafted a clinical trial protocol synopsis, which we believe will assist us in preparing an application for orphan status designation


We are getting ever so close with this study becoming a life changing event for those with MM and shareholders whose stock will sky rocket.